Literature DB >> 7367810

An improved co-precipitation assay for determination of thyroglobulin antibodies.

J Date, U Feldt-Rasmussen, P H Petersen, K Bech.   

Abstract

A radioassay for determination of thyroglobulin antibodies in human serum using [125I]thyroglobulin co-precipitated with antihuman IgG is described. Serial dilutions of the antibody containing sera gave nearly rectilinear and parallel logit-log curves in conditions of moderate antigen excess. A secondary standard serum calibrated against the Medical Research Council Research standard A 65/93, which by definition c;ntains 1 Mega unit/1 (MU/1) was used for standardization. The mean imprecision in the concentration range 0.74-241 MU/1 was CV = 3% (within assay) and CV = 8% (total). The detection limit was 0.002 MU/1. The assay was compared to an antigen binding capacity method with an imprecision of 15% (total) and a detection limit of 0.1 MU/1. The coefficient of correlation between the two methods was: R = 0.997 (our method = 0.019 x antigen binding capacity -0.33). Based on this 1 Mega unit was found equivalent to 53 nmol thyroglobulin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7367810     DOI: 10.3109/00365518009091525

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  Thyroid function in patients with Pendred's syndrome.

Authors:  J Friis; T Johnsen; U Feldt-Rasmussen; K Bech; T Friis
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

2.  Serum thyroglobulin concentration in nontoxic goiter and response to surgery with special reference to risk of goiter relapse.

Authors:  U Feldt-Rasmussen; M Blichert-Toft; J Date; V Haas
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  European interlaboratory comparison of serum thyroglobulin measurement.

Authors:  U Feldt-Rasmussen; M Schlumberger
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

4.  The measurement of antithyroglobulin autoantibodies in the presence of thyroglobulin.

Authors:  A J Henniker; B M Luttrell; P Ward; J N Stiel; E G Wilmshurst
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

5.  Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter.

Authors:  U Feldt-Rasmussen; P H Petersen; J Date; C M Madsen
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

6.  Thyroid stimulating antibodies in rheumatoid arthritis: an in vitro phenomenon.

Authors:  C Kirkegaard; K Bech; H Bliddal; B Danneskiold-Samsoe; U Feldt-Rasmussen
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

7.  Short-term beta-adrenergic blockade decreases serum thyroglobulin in hyper- and euthyroid patients.

Authors:  H Perrild; U Feldt-Rasmussen; L Kayser; J Mølholm Hansen
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.